ConCallIQ
Go Pro
SATKARTARLIFE Healthcare 15 May 2026

Sat Kartar Life Limited — Q4 FY26

Sat Kartar Life delivered a strong Q4 FY26 with revenue crossing ₹200 crore (up 23% YoY), EBITDA up 73%, and PAT up 74%.

bullish high
Compare with...
Revenue ₹200 Cr +23%
EBITDA +73%
PAT +74%
EBITDA Margin
Duration 58 min
Read Time 1 min read

Financial stats pending filing verification

Risk Intelligence

Material risks this quarter

Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.

Risks

R

Hospital occupancy ramp-up risk

Current hospital occupancy is below 10% and break-even is not yet achieved; slower-than-expected ramp-up could delay profitability.

high · analyst_question
R

RBI approval delay for US subsidiary

RBI approval for the US subsidiary is pending, which could delay equity infusion and operational scaling.

medium · analyst_question
R

High advertisement spend as % of revenue

Advertisement spend remains at 40% of revenue, limiting margin expansion; management expects only gradual reduction to 38%.

medium · management_commentary
R

Working capital strain from hospital expansion

Hospital business requires significant working capital (50% of bed cost), and cash generation has been weak in FY26.

medium · data_observation